raj Quest

raj Quest —40 Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Phone: 561.366.0084 Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR8391 ION Requisition: 0006872 Collected: Received: Reported: 11/23/2018 11/23/2018 / 21:23 EST 11/24/2018 / 06:36 EST Test Nana In Range PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS PROTEIN, TOTAL, SERUM PROTEIN, TOTAL 7.1 LIPID PANEL, STANDARD CHOLESTEROL, TOTAL HOL CHOLESTEROL TRIGLYCERIDES LDL—CHOLESTEROL Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401.3418 Out Of Range Reference Range 6.1-8.1 g/dL 216 H <200 mg/dL 23 L >40 mg/dL 935 H <150 mg/dL LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Reference range: <100 Desirable range <100 mg/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO 9.4 H NON HDL CHOLESTEROL 193 H For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. COMPREHENSIVE METABOLIC PANEL GLUCOSE 111 H For someone without known diabetes, a glucose value between 100 and 125 mg/dL is consistent with prediabetes and should be confirmed with a follow-up test. UREA NITROGEN (BUN) 20 CREATININE 0.95 For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM CHLORIDE 84 97 NOT 138 4.4 105 APPLICABLE mg/dL (talc) <5.0 (talc) <130 mg/dL (talc) 65-99 mg/dL Fasting reference interval 7-25 mg/dL 0.70-1.25 mg/dL > OR = 60 mL/min/1.73m2 > OR = 60 mL/min/1.73m2 6-22 (talc) 135-146 mmol/L 3.5-5.3 mmolife 98-110 mmol/L Lab MI MI MI MI MI MI MI MI CLIENTSERVICES:866.6971378 SPECIMEN: MR839110N Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGEI0F4 EFTA00804470 Quest Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR8391 ION Collected: 11/23/2018 Received: 11/23/2018 / 21:23 EST Reported: 11/24/2018 106:36 EST Client #: 78300020 MOSKOWITZ, BRUCE W Test Name In Range Out Of Range Reference Range Lab CARBON DIOXIDE 24 20-32 mmol/L CALCIUM 9.9 8.6-10.3 mg/dL PROTEIN, TOTAL 7.1 6.1-8.1 g/dL ALBUMIN 4.4 3.6-5.1 g/dL GLOBULIN 2.7 1.9-3.7 g/dL (calc) ALBUMIN/GLOBULIN RATIO 1.6 1.0-2.5 (calc) BILIRUBIN, TOTAL 0.7 0.2-1.2 mg/dL ALKALINE PHOSPHATASE 60 40-115 U/L AST 23 10-35 U/L ALT 36 9-46 U/L HEMOGLOBIN Ale 5.7 R <5.7 % of total Hgb MI For someone without known diabetes, a hemoglobin Ale value between 5.7% and 6.4% is consistent with prediabetes and should be confirmed with a follow-up test. For someone with known diabetes, a value <7% indicates that their diabetes is well controlled. Ale targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations. This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Ale for diagnosis of diabetes for children. URIC ACID Therapeutic target 6.9 for gout patients: <6.0 mg/dL TSH 2.44 T4 (THYROXINE), TOTAL 7.6 FREE T4 INDEX (T7) 2.3 T3 UPTAKE 30 SED RATE BY MODIFIED WESTERGREN 11 CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT 6.0 RED BLOOD CELL COUNT 5.28 HEMOGLOBIN 15.4 HEMATOCRIT 44.3 MCV 83.9 MCH 29.2 MCHC 34.8 RDW 13.0 PLATELET COUNT 273 MPV 10.6 ABSOLUTE NEUTROPHILS 2892 ABSOLUTE LYMPHOCYTES 2298 ABSOLUTE MONOCYTES 492 ABSOLUTE EOSINOPHILS 270 ABSOLUTE BASOPHILS 48 NEUTROPHILS 48.2 LYMPHOCYTES 38.3 MONOCYTES 8.2 4.0-8.0 mg/dL 0.40-4.50 mIU/L 4.9-10.5 mcg/dL 1.4-3.8 22-35 % < OR = 20 mm/h 3.8-10.8 Thousand/uL 4.20-5.80 Million/uL 13.2-17.1 g/dL 38.5-50.0 % 80.0-100.0 fL 27.0-33.0 pg 32.0-36.0 g/dL 11.0-15.0 % 140-400 Thousand/uL 7.5-12.5 fL 1500-7800 cells/uL 850-3900 cells/uL 200-950 cells/uL 15-500 cells/uL 0-200 cells/uL MI MI MI MI MI MI CLIENTSERIIICES:866.6971378 SPECIMEN: MR839110N Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 2 OF 4 EFTA00804471 Quest Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Clientheonnation EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: Collected: Received: Reported: MR83911ON 11/23/2018 11/23/2018 / 21:23 EST 11/24/2018 / 06:36 EST Client #: 78300020 MOSKOWITZ, BRUCE W Test Name In Range Out Of Range Reference Range Lab EOSINOPHILS 4.5 BASOPHILS 0.8 IRON AND TOTAL IRON BINDING CAPACITY IRON, TOTAL 91 50-180 mcg/dL MI IRON BINDING CAPACITY 336 250-425 mcg/dL (calc) % SATURATION 27 15-60 % (calc) PSA, TOTAL 0.6 < OR = 4.0 ng/mL MI The total PSA value from this assay system is standardized against the WHO standard. The test result will be approximately 20% lower when compared to the equimolar-standardized total PSA (Beckman Coulter). Comparison of serial PSA results should be interpreted with this fact in mind. This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. CLIENT SERVICES: 866.697.8378 SPECIMEN: MR8391 ION Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE30F4 EFTA00804472 j Quest Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR8391 ION Collected: 11/23/2018 Received: 11/23/2018 / 21:23 EST Reported: 11/24/2018 1 06:36 EST Client #: 78300020 MOSKOWITZ, BRUCE W Endocrinology Test Name Result Reference Range Lab ' VITAMIN D,25-OH,TOTAL,IA Vitamin D Status Deficiency: Insufficiency: Optimal: 25-OH Vitamin D: <20 ng/mL 20 - 29 ng/mL > or = 30 ng/mL 24 L 30-100 ng/mL MI For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: httpJ/education.questdiagnostics.com/faq/FAO163 (This link is being provided for informational/ educational purposes only.) Physician Comments: PENDING TESTS: PROTEIN ELECTROPHORESIS FERRMN HS CRP VITAMIN B12 HOMOCYSTEINE C-REACTIVE PROTEIN CALCIUM, IONIZED MERCURY. BLOOD IMMUNOFIXATION, SERUM TESTOSTERONE FREE (DIALYSIS) AND TOTAL.MS URINALYSIS, COMPLETE PERFORMING SITE: MI QUEST DIAGNOSTICS.MIAMI. HMO COMMERCE PARKWAY. MIRAMAR. FL MOIS.39.18 Laboratocc Outdo': JULIE I. FRIEDMAN.MD.CLIA. IOD0277312 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR8391 I0N PAGE 4 OF 4 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00804473